Children and youth in Uganda, age 4-26 years at the beginning of the baseline assessment
T1D (determined by clinical criteria, as autoantibody testing is not regionally available) of at least 12 months duration at the beginning of the baseline assessment
Receiving insulin therapy
Access to a cell phone (nearly ubiquitous in Uganda, even in remote areas)
At least one parent or guardian (or as per local regulations) is present in clinic and able to give consent for children under 18 years of age (those age 18-26 may give consent for themselves)
You may not be if
Unwilling or unable to be seen monthly at the pediatric diabetes clinic
Pregnant or breast-feeding; women likely to become pregnant in the next year
Major medical conditions which the investigator feels would interfere with study participation
Patient already has CGM
Inability during the baseline assessment period to wear the sensor for at least 7 days or return it
Participant deemed unlikely or unable to comply with the protocol
